Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines

Procedia in Vaccinology

Volumn 5, Issue , 2011, Pages 200-212

  Stickings, Paul ^a   Rigsby, Peter ^a   Coombes, Laura ^a   Hockley, Jason ^a   Tierney, Rob ^a   Sesardic, Dorothea ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Diphtheria; Reduction; Refinement; Serology; Tetanus; Vaccine potency

Indexed keywords

DIPHTHERIA TETANUS VACCINE;

ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL USE; ARTICLE; EXPERIMENTAL ANIMAL; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; UNITED KINGDOM; VALIDATION STUDY;

EID: 84555196669     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.020     Document Type: Article

References (28)

1. Borrow R, Balmer P, Roper MH. The immunological basis for immunization series. Module 3: Tetanus update 2006. Immunization, Vaccines and Biologicals. Geneva: World Health Organization, 2007. Available at: www.who.int/vaccines-documents/DocsPDF07/869.pdf.
2. Scheifele DW, Ochnio JJ. The Immunological Basis for Immunization Series. Module 2: Diphtheria Update 2009. Immunization, Vaccines and Biologicals. Geneva: World Health Organization, 2009. Available at: whqlibdoc.who.int/publications/2009/9789241597869_eng.pdf.
3. Rappuoli R. New and improved vaccines against diphtheria and tetanus. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, editors. New Generation Vaccines, 2nd Edition. New York: Marcel Dekker, 1997: 417-36.
4. Coombes L, Stickings P, Tierney R, Rigsby P, Sesardic D. Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines. J Immunol Methods 2009;350:142-9.
5. World Health Organization. Requirements for diphtheria, tetanus, pertussis and combined vaccines. In: WHO Expert Committee on Biological Standardization. Fortieth Report. Geneva, World Heatlh Organization, 1990, Annex 2 (WHO Technical Report Series, No. 800). Available at: http://www.who.int/biologicals/publications/trs/areas/vaccines/dtp/en/index.html.
6. World Health Organization. Recommendations for diphtheria, tetanus, pertussis and combined vaccines (Amendments 2003). In: WHO Expert Committee on Biological Standardization. Fifty-fourth Report. Geneva, World Health Organization, 2005, Annex 5 (WHO Technical Report Series, No. 927). Available at: http://www.who.int/biologicals/publications/trs/areas/vaccines/dtp/en/index.html.
7. Assay of diphtheria vaccine (adsorbed). General Chapter 2.7.6. In: European Pharmacopoeia, 6th edition. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2008.
8. Assay of tetanus vaccine (adsorbed). General Chapter 2.7.8. In: European Pharmacopoeia, 6th edition. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2008.
9. Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R. Calibration of replacement International Standard and European Pharmacopoeia Biological Reference Preparation for tetanus toxoid, adsorbed. Biologicals 2002;30:49-68.
10. Stickings P, Rigsby P, Coombes L, Malik K, Matejtschuk P, Sesardic D. Collaborative study for the calibration of a replacement International Standard for diphtheria toxoid adsorbed. Biologicals 2010;38(5):529-38.
11. Winsnes R, Hendriksen C, Sesardic D, Akkermans A, Daas A. Serological assays as alternatives to the Ph Eur challenge test for batch release of tetanus vaccines for human use. Dev Biol Stand 1999;101:277-88.
12. Winsnes R, Sesardic D, Daas A, Rigsby P. A Vero cell method for potency testing of diphtheria vaccines. Dev Biol (Basel) 2002;111:141-8.
13. Winsnes R, Hendriksen C. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use - summary of all three phases. Pharmeuropa Spec Issue Biol 2002; 2:1-92.
14. Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - part 1. Pharmeuropa Bio 2004;2003(2):35-68.
15. Sesardic D, Winsnes R, Rigsby P, Behr-Gross ME. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines - extended study: correlation of serology with in vivo toxin neutralisation. Pharmeuropa Bio 2004;2003(2):69-76.
16. Winsnes R, Sesardic D, Daas A, Behr-Gross ME. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines (part 2). Pharmeuropa Bio 2006; 2006(1):73-88.
17. Gupta RK, Anderson R, Cecchini D, Rost B, Griffin P Jr, Benscoter K, Xu J, Montanez-Ortiz L, Siber GR. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus, acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines. Dev Biol Stand 1996;86:283-96.
18. Winsnes R, Sesardic D, Daas A, Terao E, Behr-Gross ME. Collaborative study on a guinea pig serological method for the assay of acellular pertussis vaccines. Pharmeur Bio Sci Notes 2009;2009(1):27-40.
19. Redhead K, Sesardic D, Yost SE, Attwell A-M, Watkins J, Hoy CS, Plumb JE, Corbel MJ. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity. Biologicals 1994;22(4):339-45.
20. Gupta RK, Anderson R, Cecchini D, Rost B, Xu J, Gendreau K, Saroff DL, Marchant C, Siber GR. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and Haemophilus influenzae type b capsular polysaccharide conjugate vaccine. Biologicals 1999; 27(2): 167-76.
21. Kondo S, Kameyama S, Murata R. Standardization and control of toxoid components in the combined vaccine (DPT). Jpn J Med Sci Biol 1974;27(6):315-19.
22. Sesardic D, Dawes CS, McLellan K, Durrani Z, Yost SE, Corbel MJ. Non-pertussis components of combination vaccines: problems with potency testing. Biologicals 1999;27(2):177-81.
23. Hendriksen CFM, Garthoff B, Aggerbeck H, Bruckner L, Castle P, Cussler K, Dobbelaer R, van de Donk H, van der Gund J, Lefrancois S, Milstien J, Minor PD, Maugeot H, Rombaut B, Ronneberger HD, Spieser J-M, Stolp R, Straughan DW, Tollis M, Zigtermans G. Alternatives to animal testing in the quality control of immunobiologicals: current status and future prospects. The report and recommendations of ECVAM Workshop 4. Altern Lab Anim 1994;22:420-34.
24. Miyamura K, Nishio S, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand 1974;2(3):189-201.
25. Aggerbeck H, Heron I. Improvement of a Vero cell assay to determine diphtheria antitoxin content in sera. Biologicals 1991;19(2):71-6.
26. Statistical analysis of results of biological assays and tests. General Chapter 5.3. In: European Pharmacopoeia, 6th edition. Strasbourg: Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2008.
27. Dobbelaer R, Knight P, Lyng J. Use and validation of a single vaccine dilution assay for testing the potency of diphtheria, tetanus and combined vaccines. In: WHO Manual of laboratory methods: For testing of vaccines used in the WHO Expanded Programme on Immunization. Geneva: World Health Organization, 1997:162-74.
28. Hardegree MC, Pittman M, Maloney CJ. Influence of mouse strain on the assayed potency (unitage) of tetanus toxoid. Appl Microbiol 1972;24(1):120-6.